Related Experiment Video
Updated: Jun 7, 2026

Monitoring Dynamic Growth of Retinal Vessels in Oxygen-Induced Retinopathy Mouse Model
Published on: April 2, 2021
Simethicone retinopathy in an immature infant
Annie Chan1, Tony Tsai, Joan O'Brien
1Department of Ophthalmology, Stanford University School of Medicine, Stanford, California, USA.
Insights
Simethicone, an over-the-counter colic medication, may cause retinal lesions in infants. These findings suggest an embolic phenomenon possibly linked to systemic drug absorption.
Area of Science:
- Ophthalmology
- Pediatrics
- Pharmacology
Background:
- Colic is a common issue in infants.
- Simethicone is a widely used over-the-counter medication for infant colic.
- Systemic absorption of medications in infants can lead to various complications.
Observation:
- Retinal findings were observed in an immature infant.
- The infant was consuming simethicone for colic treatment.
- The observed retinal lesions were consistent with an embolic phenomenon.
Findings:
- The retinal lesions suggest an embolic event.
- Systemic absorption of simethicone is a potential cause.
- This case highlights a possible adverse effect of simethicone in infants.
Implications:
- This case may inform clinical practice regarding simethicone use in infants.
- Further research is needed to confirm the link between simethicone and retinal emboli.
- Awareness of potential ocular complications is crucial for pediatricians and ophthalmologists.
Abstract:
The authors describe retinal findings in an immature infant consuming simethicone, a common over-the-counter drug used in the treatment of colic. The lesions are most consistent with an embolic phenomenon possibly from systemic absorption of a medication such as simethicone.
Related Concept Videos
Diabetic Retinopathy
The Retinoblastoma Gene
The first-ever tumor suppressor gene called Rb was identified in retinoblastoma - a rare eye tumor in children. In inherited forms of the disease, a child inherits one defective copy of the Rb gene, which predisposes them to retinoblastoma. However,...
